ADCT vs JNJ: Which Stock is Better?
Side-by-side comparison of ADC Therapeutics SA and Johnson & Johnson in 2026
ADCT
ADC Therapeutics SA
$3.52
JNJ
Johnson & Johnson
$218.21
Key Metrics Comparison
| Metric | ADCT | JNJ | Winner |
|---|---|---|---|
| Market Cap | $436.05M | $525.73B | JNJ |
| P/E Ratio | N/A | 21.10 | JNJ |
| EPS (TTM) | $N/A | $10.34 | JNJ |
| Revenue Growth | -0.1% | 0.1% | JNJ |
| Gross Margin | -57.4% | 68.4% | JNJ |
Analyze ADCT
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ADCT or JNJ a better investment?
Comparing ADCT and JNJ: ADC Therapeutics SA has a market cap of $436.05M while Johnson & Johnson has $525.73B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ADCT and JNJ?
ADCT (ADC Therapeutics SA) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ADCT or JNJ?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ADCT or JNJ?
JNJ has higher revenue growth at 0.1% vs -0.1% for ADCT.
Which company is more profitable: ADCT or JNJ?
Johnson & Johnson (JNJ) has higher gross margins at 68.4% compared to -57.4% for ADCT.
Which is the larger company: ADCT or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $525.73B compared to $436.05M for ADCT.
Should I buy ADCT or JNJ in 2026?
Both ADCT and JNJ have investment merit. ADCT trades at $3.52 while JNJ trades at $218.21. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ADCT and JNJ stock?
Key differences: Market Cap ($436.05M vs $525.73B), P/E Ratio (N/A vs 21.1x), Revenue Growth (-0.1% vs 0.1%), Gross Margin (-57.4% vs 68.4%).